China set to complete food and drug system reform this year, reports People's Daily

8 August 2013

China expects to complete its reform of local food and drug administration systems by the end of this year to better ensure food and drug safety, according to the local newspaper People's Daily, reported by the official news agency Xinhua.

A unified supervision and management system will be formed to encompass state- and local-level food and drug administration systems across the country by the end of this year, Zhang Yong, head of the China Food and Drug Administration (CFDA), said in an interview with the People's Daily. He said 10 provincial regions in China have already completed these reforms.

State-level food and drug administration system reform was completed by the end of May, according to the report. The reform is meant to substantially enhance the capabilities of supervision and management of food and drug safety, said Zhang.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical